Top Markets
Coin of the day
PreveCeutical Medical Inc. PreveCeutical Medical Inc.

PreveCeutical Medical Inc.

PREV
Clasificación en acciones #33936
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating... PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.
Precio por acción
$0.01100905
Última sincronización: 2026-08-13
Capitalización bursátil
$6.59M
Cambio (1 día)
0.00%
Cambio (1 año)
-49.29%
País
CA
Comercio PreveCeutical Medical Inc. (PREV)

Categoría

Ingresos de PreveCeutical Medical Inc. (PREV)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de PreveCeutical Medical Inc., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de PreveCeutical Medical Inc. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$12.62B -
US
$6.02B -
NL
- -
CH
- -
KR
$10.11B -
BE